This inventor holds 1 USPTO granted patent. Top assignee: Temasek Life Sciences Laboratory Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Hui Kheng Chua: Innovator in Vaccine Development
Introduction
Hui Kheng Chua is a notable inventor based in Singapore, recognized for his contributions to the field of vaccine development. His work primarily focuses on the Porcine Circovirus Type 2 (PCV2), which has significant implications for veterinary medicine and animal health.
Latest Patents
Hui Kheng Chua holds a patent for the development of Porcine circovirus type 2 vaccines. This invention is based on the ORF3 gene of PCV2 and identifies its apoptotic role. This groundbreaking discovery has led to the creation of an attenuated live vaccine against PCV2, which is crucial for preventing diseases in pigs.
Career Highlights
Hui Kheng Chua is affiliated with Temasek Life Sciences Laboratory Limited, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of PCV2 and improving vaccine efficacy.
Collaborations
Hui Kheng Chua has collaborated with notable colleagues, including Hwei-Sing Jimmy Kwang and Isabelle Gek Joo Chen. These partnerships have enhanced the research efforts and contributed to the successful development of innovative solutions in the field.
Conclusion
Hui Kheng Chua's contributions to vaccine development, particularly in relation to Porcine Circovirus Type 2, highlight his role as an important figure in the field of veterinary medicine. His innovative work continues to impact animal health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile